1. An open-label, single-arm phase II clinical study of docetaxel plus lobaplatin for Chinese patients with pulmonary and hepatic metastasis of nasopharyngeal carcinoma
   Shuai Zhang et al, 2016, Anti-Cancer Drugs CrossRef
2. Emerging Trends in Metal‐based Anticancer Agents: Drug Design to Clinical Trials and their Mechanism of Action
   Achamo Temesgen et al, 2023, ChemistrySelect CrossRef
3. Metal-based Complexes as Potential Anti-cancer Agents
   Sabyasachi Banerjee et al, 2022, Anti-Cancer Agents in Medicinal Chemistry CrossRef
4. Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy with lobaplatin and docetaxel to treat synchronous peritoneal carcinomatosis from gastric cancer: Results from a Chinese center
   H.-T. Wu et al, 2016, European Journal of Surgical Oncology (EJSO) CrossRef
5. Lobaplatin Inhibits Prostate Cancer Proliferation and Migration Through Regulation of BCL2 and BAX
   Hongwen Cao et al, 2019, Dose-Response CrossRef
6. An overview on ligands of therapeutically interest
   Julia Martín, 2018, Pharmacy & Pharmacology International Journal CrossRef
7. A randomized and open-label phase II trial reports the efficacy of neoadjuvant lobaplatin in breast cancer
   Xiujuan Wu et al, 2018, Nature Communications CrossRef
8. Evaluation of Antiproliferative Palladium(II) Complexes of Synthetic Bisdemethoxycurcumin towards In Vitro Cytotoxicity and Molecular Docking on DNA Sequence
   Natalia Miklášová et al, 2021, Molecules CrossRef
9. Dose Escalation of Lobaplatin Concurrent with IMRT for the Treatment of Stage III-IVb NPC: A Phase I Clinical Trial
   Si-Yang Wang et al, 2018, Translational Oncology CrossRef
10. Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy with lobaplatin and docetaxel improves survival for patients with peritoneal carcinomatosis from abdominal and pelvic malignancies
    Hai-Tao Wu et al, 2016, World Journal of Surgical Oncology CrossRef
11. Lobaplatin-based regimens outperform cisplatin for metastatic breast cancer after anthracyclines and taxanes treatment
    Zhipeng Wang et al, 2018, Saudi Journal of Biological Sciences CrossRef
12. Inorganic Coordination Chemistry: Where We Stand in Cancer Treatment?
    Pedro Pedrosa et al, 2018, Basic Concepts Viewed from Frontier in Inorganic Coordination Chemistry CrossRef
13. Comparison of the short‐term efficacy and serum markers between lobaplatin/paclitaxel‐ And carboplatin/paclitaxel‐based adjuvant chemotherapy in patient with ovarian cancer
    Wei Wang et al, 2021, Journal of Clinical Pharmacy and Therapeutics CrossRef
14. Metallo-Drugs in Cancer Therapy: Past, Present and Future
    Roxana Liana Lucaciu et al, 2022, Molecules CrossRef
15. Pharmacokinetics and safety of lobaplatin plus etoposide in Chinese men older than 65 years with extensive-stage small cell lung cancer: a phase II clinical trial
    Jianhua Chen et al, 2019, Cancer Chemotherapy and Pharmacology CrossRef
16. Advances in Metallodrug‐Driven Combination Therapy for Treatment of Cancer
    Rishabha Malviya et al, 2023, Multi‐Drug Resistance in Cancer CrossRef
17. Pilot study of docetaxel combined with lobaplatin or gemcitabine for recurrent and metastatic breast cancer
    Fenghu Li et al, 2019, Medicine CrossRef
18. Simultaneous quantitation of two diastereoisomers of lobaplatin in rat plasma by supercritical fluid chromatography with tandem mass spectrometry and its application to a pharmacokinetic study
    Xiangjun Meng et al, 2015, Journal of Separation Science CrossRef
19. Drimia calcarata Bulb Extracts Deactivate the PI3K Signalling Pathway in Cervical HPV-18 Positive HeLa Cells
    Kagiso Laka et al, 2022, Clinical Complementary Medicine and Pharmacology CrossRef